Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-012638

NPS PHARMACEUTICALS INC · NPSP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Roger Garceau
Officer — SVP & CMO
Period of report
Feb 7, 2015
Accepted (ET)
Feb 20, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 7, 2015J15,168—A41,448D
Common StockFeb 7, 2015F5,438$45.85D36,010D
Common StockF4Feb 12, 2015M3,832—A39,842D
Common StockFeb 12, 2015F1,564$45.85D38,278D
Common StockF4Feb 13, 2015M10,531—A48,809D
Common StockFeb 13, 2015F5,460$45.88D43,349D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6—Feb 12, 2015M3,832D——Common Stock3,8327,665D
Restricted Stock UnitsF5,F7—Feb 12, 2015A10,905A——Common Stock10,90510,905D
Restricted Stock UnitsF5,F8—Feb 13, 2015M10,531D——Common Stock10,53110,531D

Explanation of responses